The intracellular genistein metabolite 5,7,3',4'-tetrahydroxyisoflavone mediates G2-M cell cycle arrest in cancer cells via modulation of the p38 signaling pathway.

The intracellular genistein metabolite 5,7,3',4'-tetrahydroxyisoflavone mediates G2-M cell cycle arrest in cancer cells via modulation of the p38 signaling pathway. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The intracellular genistein metabolite 5,7,3',4'-tetrahydroxyisoflavone mediates G2-M cell cycle arrest in cancer cells via modulation of the p38 signaling pathway. Abstract Text:

Dominique T Nguyen,Eva Hernandez-Montes,David Vauzour,Axel H ,Catherine Rice-Evans,Enrique Cadenas,Jeremy P E Spencer,

The cellular actions of genistein are believed to mediate the decreased risk of breast cancer associated with high soy consumption. We have investigated the intracellular metabolism of genistein in T47D tumorigenic and MCF-10A nontumorigenic cells and assessed the cellular actions of resultant metabolites. Genistein selectively induced growth arrest and G2-M phase cell cycle block in T47D but not MCF10A breast epithelial cells. These antiproliferative effects were paralleled by significant differences in the association of genistein to cells and in particular its intracellular metabolism. Genistein was selectively taken up into T47D cells and was subject to metabolism by CYP450 enzymes leading to the formation of both 5,7,3',4'-tetrahydroxyisoflavone (THIF) and two glutathionyl conjugates of THIF. THIF inhibited cdc2 activation via the phosphorylation of p38 MAP kinase, suggesting that this species may mediate genistein's cellular actions. THIF exposure activated p38 and caused subsequent inhibition of cyclin B1 (Ser 147) and cdc2 (Thr 161) phosphorylation, two events critical for the correct functioning of the cdc2-cyclin B1 complex. We suggest that the formation of THIF may mediate the cellular actions of genistein in tumorigenic breast epithelial cells via the activation of signaling through p38.

The intracellular genistein metabolite 5,7,3',4'-tetrahydroxyisoflavone mediates G2-M cell cycle arrest in cancer cells via modulation of the p38 signaling pathway. Publishing Authors By Initials

DT Nguyen,E Hernandez-Montes,D Vauzour,AH ,C Rice-Evans,E Cadenas,JP Spencer,

For similar enzymes and coenzymes: enzymes: transferases: phosphotransferases: phosphotransferases (alcohol group acceptor): protein kinases: protein-serine-threonine kinases: mitogen-activated protein kinases: p38 mitogen-activated protein kinases research abstracts see: enzymes and coenzymes: enzymes: transferases: phosphotransferases: phosphotransferases (alcohol group acceptor): protein kinases: protein-serine-threonine kinases: mitogen-activated protein kinases: p38 mitogen-activated protein kinases research

PUBMED ID PMID:

MEDLINE DATE:

The intracellular genistein metabolite 5,7,3',4'-tetrahydroxyisoflavone mediates G2-M cell cycle arrest in cancer cells via modulation of the p38 signaling pathway. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Free radical biology & medicine

VOLUME: 41

Page Numbers: 1225-39

Journal Abbreviation: Free Radic. Biol. Med.

ISSN: 0891-5849

DAY: 15

MONTH: 07

YEAR: 2006

The intracellular genistein metabolite 5,7,3',4'-tetrahydroxyisoflavone mediates G2-M cell cycle arrest in cancer cells via modulation of the p38 signaling pathway. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8709159

The intracellular genistein metabolite 5,7,3',4'-tetrahydroxyisoflavone mediates G2-M cell cycle arrest in cancer cells via modulation of the p38 signaling pathway. Keywords Mesh Terms:

KEYWORDS: p38 Mitogen-Activated Protein Kinases

MESH TERMS: metabolism

Chemical & Substance for Abstract: The intracellular genistein metabolite 5,7,3',4'-tetrahydroxyisoflavone mediates G2-M cell cycle arrest in cancer cells via modulation of the p38 signaling pathway. Information

Substance Name: p38 Mitogen-Activated Protein Kinases

Registry Number: EC 2.7.1.37

Grant and Affiliation Information for The intracellular genistein metabolite 5,7,3',4'-tetrahydroxyisoflavone mediates G2-M cell cycle arrest in cancer cells via modulation of the p38 signaling pathway.

AFFILIATION: Department of Molecular Pharmacology & Toxicology, School of Pharmacy, University of Southern California, Los Angeles, CA 90089, USA.

Country: United States

AGENCY: United States NIA

GRANT: AG016718

ACRONYM: AG

MEDLINETA: Free Radic Biol Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The intracellular genistein metabolite 5,7,3',4'-tetrahydroxyisoflavone mediates G2-M cell cycle arrest in cancer cells via modulation of the p38 signaling pathway Related Publications

• Abuse of the disabled child: a systematic review of population-based studies.
• Adjuvant rituximab causes prolonged hypogammaglobulinaemia following autologous stem cell transplant for non-Hodgkin's lymphoma.
• Bioinformatic prediction of polymerase elements in the rotavirus VP1 protein.
• Biosynthesis of butirosin: transfer and deprotection of the unique amino acid side chain.
• Calibration algorithm for eyetracking with unrestricted head movement.
• Carving up space at imaginary joints: can people mentally impose arbitrary spatial category boundaries?
• Characterization of photopolymerization of dentin adhesives as a function of light source and irradiance.
• Cholesterol surrogates incorporating a benzophenone as part of the sterol tetracycle.
• Differential responses of hypothalamus-pituitary-adrenal axis immediate early genes to corticosterone and circadian drive.
• Effects of formalin fixation and collagen cross-linking on T2 and magnetization transfer in bovine nasal cartilage.
• Fuzzy clustering of Raman spectral imaging data with a wavelet-based noise-reduction approach.
• Hypomagnesaemia in cystic fibrosis patients referred for lung transplant assessment.
• Identification of putative in vivo substrates of calpain 3 by comparative proteomics of overexpressing transgenic and nontransgenic mice.
• Introduction: ethics committees and failure to thrive.
• Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function.
• Mixed amphetamine salts extended release for the treatment of ADHD in adolescents: current evidence.
• Nonsteroidal benzophenone-containing analogues of cholesterol.
• Pharmacokinetics and safety of arginine supplementation in animals.
• Planning "discrete" movements using a continuous system: insights from a dynamic field theory of movement preparation.
• Pregnancy and interferon tau regulate RSAD2 and IFIH1 expression in the ovine uterus.
• Progesterone regulation of preimplantation conceptus growth and galectin 15 (LGALS15) in the ovine uterus.
• Regulation of the M-cadherin-beta-catenin complex by calpain 3 during terminal stages of myogenic differentiation.
• Restorative service trends in private general practice in Australia: 1983-1999.
• Short-term cardiovascular effects of mixed amphetamine salts extended release in children and adolescents with oppositional defiant disorder.
• Synthesis of benzophenone-containing fatty acids.
• The cytomegalovirus homolog of interleukin-10 requires phosphatidylinositol 3-kinase activity for inhibition of cytokine synthesis in monocytes.
• The energy dependence syndrome.
• The intracellular genistein metabolite 5,7,3',4'-tetrahydroxyisoflavone mediates G2-M cell cycle arrest in cancer cells via modulation of the p38 signaling pathway.
• WNTs in the ovine uterus: potential regulation of periimplantation ovine conceptus development.
• Worsening of quality of life after epilepsy surgery: effect of seizures and memory decline.